Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?

Table 3 Control rates of LNs

LNs	Total	Controlled, n (%)	P value
All LNs	1310	1276 (97.4%)
LNs < 1 cm	878	873 (99.4%)	0.000
LNs 1–2 cm	374	359 (96%)
LNs ≥ 2 cm	58	44 (75.9%)
All LNs	1310	1276 (97.4%)
≤ 50.4 Gy	413	403 (97.6%)	0.257
50.4–60 Gy	703	681 (96.9%)
> 60 Gy	194	192 (99%)
LNs < 1 cm	878	873 (99.4%)
≤ 50.4 Gy	334	332 (99.4%)	0.647
50.4–60 Gy	420	417 (99.3%)
> 60 Gy	124	124 (100%)
LNs 1–2 cm	374	359 (96%)
≤ 50.4 Gy	73	68 (93.2%)	0.135
50.4–60 Gy	242	232 (95.9%)
> 60 Gy	59	59 (100%)
LNs 1–2 cm
< 55 Gy	171	160 (93.6%)	0.028
≥ 55 Gy	203	199 (98%)
LNs 1–2 cm
≥ 55 Gy and ≤ 60 Gy	122	119 (97.5%)	1.000
> 60 Gy	81	80 (98.8%)
LNs ≥ 2 cm	58	44 (75.9%)
≤ 50.4 Gy	6	3 (50%)	0.299
50.4–60 Gy	41	32 (78%)
> 60 Gy	11	9 (81.8%)
LNs ≥ 2 cm
< 55 Gy	19	12 (63.2%)	0.107
≥ 55 Gy	39	32 (82.1%)
LNs ≥ 2 cm
≥ 55 Gy and ≤ 60 Gy	26	22 (84.6%)	0.666
> 60 Gy	13	10 (76.9%)

ISSN: 1748-717X